Skip to content

Innoviva, Inc. INVA Operating Cash Flow

Operating Cash Flow at other companies

Pfizer logo
PfizerPFE
$2.62B+12.0%
Merck & Co. logo
Merck & Co.MRK
$3.92B+56.7%
AbbVie logo
AbbVieABBV
$3.83B+134%
Insmed logo
InsmedINSM
-$222.74M+15.0%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-$792.82M-426%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
-$41.89M+38.4%

Other financials

Income statement

See full
Revenue$98.0M+10.6%
Gross profit$75.8M+3.4%
Operating income$38.2M-7.9%
Net income$186.6M+501%
EPS (diluted)$2.22+400%

Balance sheet

See full
Cash & equivalents$603.1M+89.0%
Total debt$269.4M-40.3%
Total equity$1.3B
Total assets$1.8B+46.4%

Cash flow

See full
CapEx$492.0K
Free cash flow$34.8M-28.4%

Valuation

See full
Market cap$1.74B+51.8%
Enterprise value$1.4B+9.7%
P/E3.5×
P/S4.1×+1.0×

Profitability

See full
Gross margin73.7%-9.9pp
Operating margin38.1%-11.2pp
Net margin119.9%+107pp
FCF margin54.1%+5.3pp

Returns & leverage

See full
Return on equity29.1%
Debt / equity0.2×
Current ratio21.1×+18.7×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innoviva, Inc.'s operating cash flow?
Innoviva, Inc. (INVA) reported operating cash flow of $35.28M in Q1 2026.
How has Innoviva, Inc.'s operating cash flow changed year-over-year?
Innoviva, Inc.'s operating cash flow decreased by 27.4% year-over-year, from $48.62M to $35.28M.
What is the long-term trend for Innoviva, Inc.'s operating cash flow?
Over 4 years (2021 to 2025), Innoviva, Inc.'s operating cash flow has grown at a -14.2% compound annual growth rate (CAGR), from $363.81M to $196.93M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.